Completed • Phase NA • Stage 0, I, II, III, IV • Post-Menopausal • Interventional

The following is imported from ClinicalTrials.gov:

Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer

Brief Summary

To compare accuracy of ultrasound guided fine needle aspiration (FNA) to core needle biopsy (CNB) of ultrasound detected abnormal axillary lymph nodes in patients with newly diagnosed invasive breast cancer or suspected invasive breast cancer. Hypothesis: FNA and CNB have equivalent diagnostic accuracies In order to prove our hypothesis, we will perform FNA and CNB on the same lymph node in each consented patient. The two samples will be evaluated separately by different pathologists blinded to the material in the other sample. The results of the biopsies will be compared to the gold standard (lymph node excision).

Description

Study Design

Eligibility Criteria

Arms and Intervention

• FNA and Core biopsy

Inclusion criteria

• recent or suspected diagnosis of invasive breast cancer with abnormal ipsilateral axillary lymph node

• able to provide informed consent

Exclusion criteria

• lymph node not amenable to core biopsy

• patient is unlikely to undergo lymph node excision (i.e. elderly patient with co-morbidities)